Literature DB >> 17533009

The many effects of complement C3- and C5-binding proteins in renal injury.

Tipu S Puri1, Richard J Quigg.   

Abstract

The complement system is an important component of the innate immune system and a modulator of adaptive immunity. The entire complement system is focused on C3 and C5. Thus, there are proteins that activate C3 and C5, those that regulate this activation, and those that transduce the effects of C3 and C5 activation products; each can affect the kidney in renal injury. The normal kidney has the inherent capacity to protect itself from complement activation through cellular expression of decay-accelerating factor, membrane cofactor protein (in human beings), and Crry (in rodents). In addition, plasma factor H protects vascular spaces in the kidney. Although the main function of these proteins is to limit complement activation, there is now considerable evidence that they can transduce signals on engagement in immune cells. The G-protein-coupled 7-span transmembrane receptors for C3a and C5a, and the integral membrane complement receptors (CR) for C3b, iC3b, and C3dg, are expressed outside the kidney, particularly in cells of hematopoietic and immune lineage. These are important in renal injury through their infiltration of the kidney and/or by affecting kidney-directed immune responses. There is mounting evidence that intrinsic glomerular and tubular cell C3aR and C5aR expression and activation also can affect renal injury. CR1 on podocytes and the beta2 integrins CR3 and CR4 in kidney dendritic cells have functions that remain poorly defined. Cells of the kidney also have the capacity to produce and activate their own complement proteins. Thus, intrinsic renal cells express decay-accelerating factor, membrane cofactor protein, Crry, C3aR, C5aR, CR1, CR3, and CR4. These can be engaged by C3 and C5 activation products derived from systemic and local pools in renal injury. Given their capacity to provide signals that influence kidney cellular behavior, their activation can have substantial effects in renal injury. Defining these in a cell- and disease-specific fashion is an exciting challenge for future research.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17533009     DOI: 10.1016/j.semnephrol.2007.02.005

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  8 in total

Review 1.  Review: Complement and its regulatory proteins in kidney diseases.

Authors:  Allison M Lesher; Wen-Chao Song
Journal:  Nephrology (Carlton)       Date:  2010-10       Impact factor: 2.506

2.  Comparative proteomic analysis of renal tissue in IgA nephropathy with iTRAQ quantitative proteomics.

Authors:  Weiguo Sui; Zhenzhen Cui; Ruohan Zhang; Wen Xue; Minglin Ou; Guimian Zou; Jiejing Chen; Yong Dai
Journal:  Biomed Rep       Date:  2014-07-23

3.  Tissue-specific deletion of Crry from mouse proximal tubular epithelial cells increases susceptibility to renal ischemia-reperfusion injury.

Authors:  Jing Miao; Allison M Lesher; Takashi Miwa; Sayaka Sato; Damodar Gullipalli; Wen-Chao Song
Journal:  Kidney Int       Date:  2014-05-21       Impact factor: 10.612

4.  Complement activation products in the circulation and urine of primary membranous nephropathy.

Authors:  Mu-Fan Zhang; Jing Huang; Yi-Miao Zhang; Zhen Qu; Xin Wang; Fang Wang; Li-Qiang Meng; Xu-Yang Cheng; Zhao Cui; Gang Liu; Ming-Hui Zhao
Journal:  BMC Nephrol       Date:  2019-08-09       Impact factor: 2.388

5.  Identifying the hub genes for Duchenne muscular dystrophy and Becker muscular dystrophy by weighted correlation network analysis.

Authors:  Junjie Wang; Qin Fan; Tengbo Yu; Yingze Zhang
Journal:  BMC Genom Data       Date:  2021-12-18

6.  The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H-deficient mice.

Authors:  Jessy J Alexander; Lee Chaves; Anthony Chang; Richard J Quigg
Journal:  Kidney Int       Date:  2012-07-25       Impact factor: 10.612

Review 7.  A compendium of urinary biomarkers indicative of glomerular podocytopathy.

Authors:  Miroslav Sekulic; Simona Pichler Sekulic
Journal:  Patholog Res Int       Date:  2013-11-13

8.  Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy.

Authors:  Khurrum Shahzad; Fabian Bock; Wei Dong; Hongjie Wang; Stefan Kopf; Shrey Kohli; Moh'd Mohanad Al-Dabet; Satish Ranjan; Juliane Wolter; Christian Wacker; Ronald Biemann; Stoyan Stoyanov; Klaus Reymann; Peter Söderkvist; Olaf Groß; Vedat Schwenger; Sascha Pahernik; Peter P Nawroth; Herman-Josef Gröne; Thati Madhusudhan; Berend Isermann
Journal:  Kidney Int       Date:  2014-07-30       Impact factor: 10.612

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.